Jordan Larry M, McVagh J R, Noga B R, Cabaj A M, Majczyński H, Sławińska Urszula, Provencher J, Leblond H, Rossignol Serge
Department of Physiology and Pathophysiology, Spinal Cord Research Centre, University of Manitoba Winnipeg, MB, Canada.
Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miami, FL, USA.
Front Neural Circuits. 2014 Nov 6;8:132. doi: 10.3389/fncir.2014.00132. eCollection 2014.
Previous experiments implicate cholinergic brainstem and spinal systems in the control of locomotion. Our results demonstrate that the endogenous cholinergic propriospinal system, acting via M2 and M3 muscarinic receptors, is capable of consistently producing well-coordinated locomotor activity in the in vitro neonatal preparation, placing it in a position to contribute to normal locomotion and to provide a basis for recovery of locomotor capability in the absence of descending pathways. Tests of these suggestions, however, reveal that the spinal cholinergic system plays little if any role in the induction of locomotion, because MLR-evoked locomotion in decerebrate cats is not prevented by cholinergic antagonists. Furthermore, it is not required for the development of stepping movements after spinal cord injury, because cholinergic agonists do not facilitate the appearance of locomotion after spinal cord injury, unlike the dramatic locomotion-promoting effects of clonidine, a noradrenergic α-2 agonist. Furthermore, cholinergic antagonists actually improve locomotor activity after spinal cord injury, suggesting that plastic changes in the spinal cholinergic system interfere with locomotion rather than facilitating it. Changes that have been observed in the cholinergic innervation of motoneurons after spinal cord injury do not decrease motoneuron excitability, as expected. Instead, the development of a "hyper-cholinergic" state after spinal cord injury appears to enhance motoneuron output and suppress locomotion. A cholinergic suppression of afferent input from the limb after spinal cord injury is also evident from our data, and this may contribute to the ability of cholinergic antagonists to improve locomotion. Not only is a role for the spinal cholinergic system in suppressing locomotion after SCI suggested by our results, but an obligatory contribution of a brainstem cholinergic relay to reticulospinal locomotor command systems is not confirmed by our experiments.
先前的实验表明,胆碱能脑干和脊髓系统参与运动控制。我们的研究结果表明,内源性胆碱能脊髓固有系统通过M2和M3毒蕈碱受体发挥作用,能够在体外新生动物制备模型中持续产生协调良好的运动活动,这使其有可能对正常运动有所贡献,并为在缺乏下行通路的情况下恢复运动能力提供基础。然而,对这些推测的测试表明,脊髓胆碱能系统在运动诱导中几乎不起作用,因为在去大脑猫中,中脑运动区(MLR)诱发的运动不受胆碱能拮抗剂的影响。此外,脊髓损伤后步行动作的发展并不需要它,因为与去甲肾上腺素能α-2激动剂可乐定显著的促运动作用不同,胆碱能激动剂并不能促进脊髓损伤后运动的出现。此外,胆碱能拮抗剂实际上能改善脊髓损伤后的运动活动,这表明脊髓胆碱能系统的可塑性变化会干扰运动而非促进运动。脊髓损伤后运动神经元胆碱能神经支配的变化并未如预期那样降低运动神经元的兴奋性。相反,脊髓损伤后“高胆碱能”状态的出现似乎增强了运动神经元的输出并抑制了运动。我们的数据还表明,脊髓损伤后胆碱能对来自肢体的传入输入有抑制作用,这可能是胆碱能拮抗剂改善运动能力的原因之一。我们的研究结果不仅表明脊髓胆碱能系统在脊髓损伤后抑制运动中起作用,而且我们的实验也未证实脑干胆碱能中继对网状脊髓运动指令系统有必然贡献。